Research roundup


Debbie Rigby takes a look at the latest in research news

Interventions Delivered in the Community Pharmacy to Manage Allergic Rhinitis

Pharmacists have a valuable role in the management of allergic rhinitis (AR) at the community pharmacy level. This systematic review of the literature shows a pharmacist plays a pivotal role in the management of AR, significantly improving the patients’ quality of life and symptom control. However, the needs of pharmacists are not being met by current practices overall, and there is inadequate counselling and treatment selection by pharmacists.

Pharmacy 2020;8:80.

Managing Allergic Rhinitis in the Pharmacy

This paper describes an integrated approach to allergic rhinitis management in community pharmacy following the 2019 ARIA in the pharmacy guidelines. The guide supports Shared responsibility among patients, pharmacists, primary care/general practitioners and specialists can ensure appropriate, safe and cost-effective medication use, and lower healthcare utilization rates. Pharmacists should consider the patient’s needs and desired outcomes for their disease and quality of life.

Pharmacy 2020;8:85.

Qualitative Exploration of Pharmacists’ Feedback Following the Implementation of an “Allergic Rhinitis Clinical Management Pathway (AR-CMaP)” in Australian Community Pharmacies

This study aimed to explore the experiences and perceptions of community pharmacists with regards to the implementation of AR management guidelines in real-life everyday practice. Pharmacists believed that their interactions with patients around their AR were enhanced through the use of appropriate tools and education. The authors suggested, if optimal AR management is to be delivered within the community pharmacy setting, the undertaking needs to be collaborative with both pharmacy assistants and general practitioners.

Pharmacy 2020;8:90.

Assessing the Travel Health Knowledge of Australian Pharmacists

This study aimed to explore the travel health knowledge of Australian pharmacists. Overall, the travel health knowledge of participants was found to be good. However, although the majority of participants were aware of the common causes of morbidity and mortality in travel health, some slightly overestimated the prevalence of malaria and were less knowledgeable about the global distribution of some diseases.

Pharmacy 2020;8:94.

 

Previous Pharmacy in the firing line
Next Tension over pharmacy trial funding

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.